Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mitoxantrone Hydrochloride Injection in Transoral Robotic Thyroid Cancer Surgery
NCT07354698Phase 4Not yet recruiting
- Start
- Feb 2026
- Primary completion
- Feb 2028
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 4 trial of mitoxantrone in papillary thyroid cancer (PTC). Planned start Feb 2026; status: not yet recruiting.
02
Drugs
mitoxantrone
03
Conditions
papillary thyroid cancer (PTC)
Beyond the preview
Go deeper on NCT07354698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07354698.